美國居民不適用 XM 服務。

Novo Nordisk says no sign of crime, links between fires at Denmark facilities



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Novo Nordisk says no sign of crime, links between fires at Denmark facilities</title></head><body>

COPENHAGEN, June 19 (Reuters) - There was no indication so far that three fires that broke out at Novo Nordisk's NOVOb.CO Danish facilities over the past month were connected or that they were caused by criminal activity, the company said on Wednesday.

A blaze at a building near the company's Bagsvaerd head office northwest of Copenhagen on Tuesday was the third in just over one month at different facilities occupied by the maker of the weight-loss treatment Wegovy and diabetes drug Ozempic.

The latest fire was quickly brought under control by the fire brigade.

"There are no signs of criminal activity at any of the three fires and no signs that they are linked to each other," a Novo Nordisk spokesperson said, adding that police were still investigating all three fires.

Danish police said the same on Wednesday about the most recent blaze .

"For now, there is no indication that there is anything criminal behind the fire, but it is of course being thoroughly investigated by the police," Copenhagen police wrote on social media platform X.

A fire was reported at a building under construction in the Danish city of Kalundborg on May 16, and later onMay 22, a blaze was reported in an office building in Bagsvaerd, the same suburb where the latest incident was reported.



Reporting by Louise Breusch Rasmussen and Jacob Gronholt-Pedersen, editing by Terje Solsvik and Bernadette Baum

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明